Abstract

A novel lysosomal alpha-mannosidase, with unique substrate specificity, has been partially purified from human spleen by chromatography through concanavalin A-Sepharose, DEAE-Sephadex, and Sephacryl S-300. This enzyme can catalyze the hydrolysis of only 1 mannose residue, that which is alpha(1----6)-linked to the beta-linked mannose in the core of N-linked glycans, as found in the oligosaccharides Man alpha(1----6)[Man alpha(1----3)] Man beta(1----4)GlcNAc and Man alpha(1----6)Man beta(1----4) GlcNAc. The newly described alpha-mannosidase does not catalyze the hydrolysis of mannose residues outside of the core, even if they are alpha(1----6)-linked, and is not active on the other alpha-linked mannose in the core, which is (1----3)-linked. The narrow specificity of the novel mannosidase contrasts sharply with that of the major lysosomal alpha-mannosidase, which is able to catalyze the degradation of oligosaccharides containing diverse linkage and branching patterns of the mannose residues. Importantly, although the major mannosidase readily catalyzes the hydrolysis of the core alpha(1----3)-linked mannose, it is poorly active towards the alpha(1----6)-linked mannose, i.e. the very same mannose residue for which the newly characterized mannosidase is specific. The novel enzyme is further differentiated from the major lysosomal alpha-mannosidase by its inability to catalyze the efficient hydrolysis of the synthetic substrate p-nitrophenyl alpha-mannoside, and by the strong stimulation of its activity by Co2+ and Zn2+. Similarly to the major mannosidase, it is strongly inhibited by swainsonine and 1,4-dideoxy-1,4-imino-D-mannitol, but not by deoxymannojirimycin. The presence of this novel alpha-mannosidase activity in human tissues provides the best explanation, to date, for the structures of the oligosaccharides stored in human alpha-mannosidosis. In this condition the major lysosomal alpha-mannosidase activity is severely deficient, but apparently the alpha(1----6)-mannosidase is unaffected, so that the oligosaccharide structures reflect the unique specificity of this enzyme.

Highlights

  • A novel lysosomal a-mannosidase, with unique sub- Our recent studieson the specificity of human, bovine, and strate specificity, has been partially purified fromhu- feline, lysosomal a-mannosidases toward natural substrates man spleen by chromatography throughconcanavalin derived from complex, hybrid, and high-mannose glycans (1, A-Sepharose, DEAE-Sephadex, and Sephacryl S-300. 2), have shown that thedegradation proceeds in anonrandom

  • The narrow specificity of the novel mined by the structure of the initial substrate.The lysosomal degradation of oligomannosyl glycans derived from N-linked glycoproteins proceeds in a cooperative bidirectional manner, by the action of the enzymes glycosylasparaginaseand endoN-acetyl-8-glucosaminidasaet thereducing terminus (3), and exo-a-mannosidase at the nonreducing terminus

  • The novel enzyme is further differentiated from presented to bovine and feline a-mannosidases, because cattle the major lysosomal a-mannosidase by its inability to and catslack the lysosomalendo-N-acetyl-8-glucosaminidase catalyze the efficient hydrolysis of the synthetic sub- activity present in humans (3-5)

Read more

Summary

MATERIALS ANDMETHODS

Due to the labor intensive preparation of the liver, or urine or pancreas from swainsonine-intoxicated sheep, as samples for HPLC analysis, routine nonquantitative assays were previously described (12-14). Their purity was assessed by HPLC4 carried out using 2b as substrate and the incubation mixtures anaanalysis and was always greater than 95% (2). Product identification was based on comparison of the concentrated by ammonium sulfate precipitation, and dialyzed against 50 mM sodium phosphate, pH 7.0 (post-ConA fraction). This fraction was found to contain the bulk of the various glycosidase activities including the a(1-6)-mannosidaseactivity. From 140 g of human spleen, 385 units, with a specific activity of 22 units/mg of protein, were prepared

RESULTS
KJn vmoc
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call